News Detail
Maryland, 8 Nov 2024: U.S. Food and Drug Administration announced it is proposing to remove oral phenylephrine as an active ingredient that can be used in over-the-counter (OTC) monograph drug products for the temporary relief of nasal congestion after an agency review of the ava......
View Details
Source : FDA News Release
U.S. Food and Drug Administration
decongestant Phenylephrine
Phenylephrine
over-the-counter (OTC) monograph
Related News
- CM Flying raid on medicine shop in Sonipat, Chemist used to keep banned medicines in car (08-11-2024)
- One died, two serious after consuming Homeopathic medicine given by a quack, arrested (08-11-2024)
- DCA seizes ayurvedic medicine for misleading claims (08-11-2024)
- More cases against Ramdev, Acharya Balkrishna in Kerala (08-11-2024)
- India's Nutraceutical Sector Eyes Global Leadership with Strategic Policy Push (08-11-2024)
- Kerala launches campaign against misuse of antibiotics (08-11-2024)
- NCS Impounds 16 Containers of Illegal Drugs from India, UK, Canada (08-11-2024)
- Overpriced antibiotic ointment seized by DCA officials in Hyderabad (07-11-2024)
- Green Pharma City taking shape, five firms plan facilities (07-11-2024)
- Banned cough syrups, counterfeit medicines seized in Cuttack (07-11-2024)